Top section
Top section
Private equity company cashes in on remaining holding after earlier divestments
Management simplified as former DCM banker joins as co-CEO
More articles
More articles
More articles
-
Emerging market equity investors are broadly optimistic in the last few days of 2018, a stark contrast to the dire mood in both US and European equity markets. -
Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.
-
Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal.
-
Bank of Jinzhou is planning to raise HK$8.22bn ($1.05bn) through a private placement of H-shares, according to a filing with the Hong Kong Stock Exchange.
-
Philippine Savings Bank wants to raise Ps8bn ($150.84m) from a rights issue early next year, fixing the price of the offering at Ps56 apiece.
-
Citi is pulling out of its China securities joint venture. It gave its partner notice at the end of last week.
Sub-sections
shared comment list
